Basit öğe kaydını göster

dc.contributor.authorKesiktas, Fatma Nur
dc.contributor.authorYildiz, Merve
dc.contributor.authorAydin, Tugba
dc.contributor.authorAlbayrak, Havva Nur
dc.contributor.authorSen, Ekin Ilke
dc.contributor.authorDernek, Bahar
dc.date.accessioned2021-03-02T16:47:11Z
dc.date.available2021-03-02T16:47:11Z
dc.identifier.citationKesiktas F. N. , Dernek B., Sen E. I. , Albayrak H. N. , Aydin T., Yildiz M., "Comparison of the short-term results of single-dose intra-articular peptide with hyaluronic acid and platelet-rich plasma injections in knee osteoarthritis: a randomized study", CLINICAL RHEUMATOLOGY, cilt.39, ss.3057-3064, 2020
dc.identifier.issn0770-3198
dc.identifier.othervv_1032021
dc.identifier.otherav_7f79c7fe-0104-4574-97a2-cc9b24a5d0ed
dc.identifier.urihttp://hdl.handle.net/20.500.12627/3288
dc.identifier.urihttps://doi.org/10.1007/s10067-020-05121-4
dc.description.abstractIntroduction/objectives Intra-articular injections may be useful in terms of pain and functional status, in knee osteoarthritis (OA). Besides hyaluronic acid (HA) and platelet-rich plasma (PRP), peptide molecules recently begin to be used. The aim of this study was to compare the efficacy of intra-articular peptide Prostrolane (R) (CAREGEN Co. Ltd.) injection with that of the HA and PRP in the persons with OA. Method Fifty-four patients with OA were included in this prospective, randomized study. Patients were randomized into three groups as intra-articular HA, peptide, and PRP groups. Paracetamol was permitted three times a day to all groups. All the patients were evaluated by the Western Ontario and McMaster Universities Arthritis Index (WOMAC), Health Assessment Questionnaire (HAQ), and visual analogue scale (VAS) at rest and during movements. Measurements performed at the baseline, after the first week of injection, and at the first and third months of follow-up. Results Mean age was 55.8 +/- 8.9 years. Forty-four (81.6%) were women. A week after the injections, rest and movement pain severity was measured by VAS decreased significantly in all the study groups (p 0.05). WOMAC pain, stiffness, function, and total scores were improved significantly in all the groups a week after the injections (p < 0.05). Improvement continued at the third month control; however, the improvement in the WOMAC pain score was significantly better in the peptide group at the third month control (p < 0.05). The decrease in the rest and movement pain was continued for 3 months except the HA group's rest pain. There were no differences among the groups for all measurements, except for the WOMAC pain score at 3 months after treatment, which was significantly lower in the peptide group. Conclusion As a result, pain relief and functional improvement were obtained after the intra-articular HA, peptide, and PRP injections in OA, and decrease in pain was better in the peptide group.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectROMATOLOJİ
dc.subjectKlinik Tıp
dc.subjectİmmünoloji ve Romatoloji
dc.subjectİç Hastalıkları
dc.subjectDahili Tıp Bilimleri
dc.subjectKlinik Tıp (MED)
dc.titleComparison of the short-term results of single-dose intra-articular peptide with hyaluronic acid and platelet-rich plasma injections in knee osteoarthritis: a randomized study
dc.typeMakale
dc.relation.journalCLINICAL RHEUMATOLOGY
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume39
dc.identifier.startpage3057
dc.identifier.endpage3064
dc.contributor.firstauthorID2485641


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster